Colleen Carpenter

Evaluation of Salmonella enterica serovar Typhi (Ty2 aroC-ssaV-) M01ZH09, with a defined mutation in the Salmonella pathogenicity island 2, as a live, oral typhoid vaccine in human volunteers

Beth D. Kirkpatrick, Robin McKenzie, John P. O’Neill et al. · Vaccine · 2005 · 99 citations

Vaccination, Serovar Typhi, Typhoid Fever +10

Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a Phase I trial

R. McKenzie, Richard I. Walker, Gary S. Nabors et al. · Vaccine · 2005 · 70 citations

Vaccination, Vaccinology, Shigella Sonnei +10

Prevalence of Norovirus among Visitors from the United States to Mexico and Guatemala Who Experience Traveler's Diarrhea

Amy R. Chapin, Colleen Carpenter, William Dudley et al. · Journal of Clinical Microbiology · 2005 · 65 citations · Full text

Comparison of the antibody in lymphocyte supernatant (ALS) and ELISPOT assays for detection of mucosal immune responses to antigens of enterotoxigenic Escherichia coli in challenged and vaccinated volunteers

Colleen Carpenter, Eric R. Hall, Roger Randall et al. · Vaccine · 2005 · 40 citations

Mucosal Vaccination, Enterotoxigenic Escherichia Coli, Pathogen Detection +10

A double-blind, placebo-controlled trial to evaluate the efficacy of PTL-003, an attenuated enterotoxigenic E. coli (ETEC) vaccine strain, in protecting against challenge with virulent ETEC

Robin McKenzie, Michael J. Darsley, Nicola Thomas et al. · Vaccine · 2008 · 38 citations

Vaccination, Vaccine Safety, Cross-protection +10